Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010, Article ID 784343, 15 pages
http://dx.doi.org/10.1155/2010/784343
Research Article

Leptin Administration Downregulates the Increased Expression Levels of Genes Related to Oxidative Stress and Inflammation in the Skeletal Muscle of ob/ob Mice

1Metabolic Research Laboratory, Clínica Universidad de Navarra 3, 31008 Pamplona, Spain
2CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Spain
3Department of Endocrinology, Clínica Universidad de Navarra, Pío XII 36, 31008 Pamplona, Spain

Received 21 January 2010; Revised 31 March 2010; Accepted 24 April 2010

Academic Editor: Giamila Fantuzzi

Copyright © 2010 Neira Sáinz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Fantuzzi and R. Faggioni, “Leptin in the regulation of immunity, inflammation, and hematopoiesis,” Journal of Leukocyte Biology, vol. 68, no. 4, pp. 437–446, 2000. View at Google Scholar · View at Scopus
  2. C. X. Andersson, B. Gustafson, A. Hammarstedt, S. Hedjazifar, and U. Smith, “Inflamed adipose tissue, insulin resistance and vascular injury,” Diabetes/Metabolism Research and Reviews, vol. 24, no. 8, pp. 595–603, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. X. Wang, Z. Hu, J. Hu, J. Du, and W. E. Mitch, “Insulin resistance accelerates muscle protein degradation: activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling,” Endocrinology, vol. 147, no. 9, pp. 4160–4168, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. L. A. Schaap, S. M. F. Pluijm, D. J. H. Deeg, and M. Visser, “Inflammatory markers and loss of muscle mass (Sarcopenia) and strength,” American Journal of Medicine, vol. 119, no. 6, pp. 526–529, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. S. K. Powers, A. N. Kavazis, and J. M. McClung, “Oxidative stress and disuse muscle atrophy,” Journal of Applied Physiology, vol. 102, no. 6, pp. 2389–2397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Sáinz, A. Rodríguez, V. Catalán et al., “Leptin administration favors muscle mass accretion by decreasing FoxO3a and increasing PGC-1α in ob/ob mice,” PLoS ONE, vol. 4, no. 9, article e6808, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, and J. M. Friedman, “Positional cloning of the mouse obese gene and its human homologue,” Nature, vol. 372, no. 6505, pp. 425–432, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. J. M. Friedman and J. L. Halaas, “Leptin and the regulation of body weight in mammals,” Nature, vol. 395, no. 6704, pp. 763–770, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. G. Frühbeck and J. Gómez-Ambrosi, “Rationale for the existence of additional adipostatic hormones,” FASEB Journal, vol. 15, no. 11, pp. 1996–2006, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. M. A. Pelleymounter, M. J. Cullen, M. B. Baker et al., “Effects of the obese gene product on body weight regulation in ob/ob mice,” Science, vol. 269, no. 5223, pp. 540–543, 1995. View at Google Scholar · View at Scopus
  11. M. Otero, R. Lago, F. Lago et al., “Leptin, from fat to inflammation: old questions and new insights,” FEBS Letters, vol. 579, no. 2, pp. 295–301, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Mancuso, A. Gottschalk, S. M. Phare, M. Peters-Golden, N. W. Lukacs, and G. B. Huffnagle, “Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia,” Journal of Immunology, vol. 168, no. 8, pp. 4018–4024, 2002. View at Google Scholar · View at Scopus
  13. S. Loffreda, S. Q. Yang, H. Z. Lin et al., “Leptin regulates proinflammatory immune responses,” FASEB Journal, vol. 12, no. 1, pp. 57–65, 1998. View at Google Scholar · View at Scopus
  14. M. A. Mandel and A. A. F. Mahmoud, “Impairment of cell-mediated immunity in mutation diabetic mice (db/db),” Journal of Immunology, vol. 120, no. 4, pp. 1375–1377, 1978. View at Google Scholar · View at Scopus
  15. R. K. Chandra, “Cell-mediated immunity in genetically obese (C57BL/6J ob/ob) mice,” American Journal of Clinical Nutrition, vol. 33, no. 1, pp. 13–16, 1980. View at Google Scholar · View at Scopus
  16. D. R. Matthews, J. P. Hosker, and A. S. Rudenski, “Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man,” Diabetologia, vol. 28, no. 7, pp. 412–419, 1985. View at Google Scholar · View at Scopus
  17. A. Katz, S. S. Nambi, K. Mather et al., “Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans,” Journal of Clinical Endocrinology and Metabolism, vol. 85, no. 7, pp. 2402–2410, 2000. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Conti, P. C. Morand, P. Levillain, and A. Lemonnier, “Improved fluorometric determination of malonaldehyde,” Clinical Chemistry, vol. 37, no. 7, pp. 1273–1275, 1991. View at Google Scholar · View at Scopus
  19. V. Catalán, J. Gómez-Ambrosi, F. Rotellar et al., “Validation of endogenous control genes in human adipose tissue: relevance to obesity and obesity-associated type 2 diabetes mellitus,” Hormone and Metabolic Research, vol. 39, no. 7, pp. 495–500, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. R. B. Ceddia, “Direct metabolic regulation in skeletal muscle and fat tissue by leptin: implications for glucose and fatty acids homeostasis,” International Journal of Obesity, vol. 29, no. 10, pp. 1175–1183, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Trostler, D. R. Romsos, W. G. Bergen, and G. A. Leveille, “Skeletal muscle accretion and turnover in lean and obese (ob/ob) mice,” Metabolism, vol. 28, no. 9, pp. 928–933, 1979. View at Google Scholar · View at Scopus
  22. G. Matarese, “Leptin and the immune system: how nutritional status influences the immune response,” European Cytokine Network, vol. 11, no. 1, pp. 7–14, 2000. View at Google Scholar · View at Scopus
  23. G. M. Lord, G. Matarese, J. K. Howard, R. J. Baker, S. R. Bloom, and R. I. Lechler, “Leptin modulates the T-cell immune response and reverses starvation—induced immunosuppression,” Nature, vol. 394, no. 6696, pp. 897–901, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. J. K. Howard, G. M. Lord, G. Matarese et al., “Leptin protects mice from starvation-induced lymphoid atrophy and increases thymic cellularity in ob/ob mice,” Journal of Clinical Investigation, vol. 104, no. 8, pp. 1051–1059, 1999. View at Google Scholar · View at Scopus
  25. A. Fortuño, G. San José, M. U. Moreno, J. Díez, and G. Zalba, “Oxidative stress and vascular remodelling,” Experimental Physiology, vol. 90, no. 4, pp. 457–462, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. J. V. Hunt, C. C. T. Smith, and S. P. Wolff, “Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose,” Diabetes, vol. 39, no. 11, pp. 1420–1424, 1990. View at Google Scholar · View at Scopus
  27. C. Feillet-Coudray, E. Rock, C. Coudray et al., “Lipid peroxidation and antioxidant status in experimental diabetes,” Clinica Chimica Acta, vol. 284, no. 1, pp. 31–43, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Muzzin, R. C. Eisensmith, K. C. Copeland, and S. L. C. Woo, “Correction of obesity and diabetes in genetically obese mice by leptin gene therapy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 25, pp. 14804–14808, 1996. View at Publisher · View at Google Scholar · View at Scopus
  29. W. I. Sivitz, S. A. Walsh, D. A. Morgan, M. J. Thomas, and W. G. Haynes, “Effects of leptin on insulin sensitivity in normal rats,” Endocrinology, vol. 138, no. 8, pp. 3395–3401, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. N. Chinookoswong, J.-L. Wang, and Z.-Q. Shi, “Leptin restores euglycemia and normalizes glucose turnover in insulin- deficient diabetes in the rat,” Diabetes, vol. 48, no. 7, pp. 1487–1492, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Maingrette and G. Renier, “Leptin increases lipoprotein lipase secretion by macrophages: involvement of oxidative stress and protein kinase C,” Diabetes, vol. 52, no. 8, pp. 2121–2128, 2003. View at Publisher · View at Google Scholar · View at Scopus
  32. A. Bouloumié, T. Marumo, M. Lafontan, and R. Busse, “Leptin induces oxidative stress in human endothelial cells,” FASEB Journal, vol. 13, no. 10, pp. 1231–1238, 1999. View at Google Scholar · View at Scopus
  33. J. Beltowski, G. Wójcicka, A. Marciniak, and A. Jamroz, “Oxidative stress, nitric oxide production, and renal sodium handling in leptin-induced hypertension,” Life Sciences, vol. 74, no. 24, pp. 2987–3000, 2004. View at Publisher · View at Google Scholar · View at Scopus
  34. V. Balasubramaniyan and N. Nalini, “Effect of leptin on peroxidation and antioxidant defense in ethanol-supplemented Mus musculus heart,” Fundamental and Clinical Pharmacology, vol. 21, no. 3, pp. 245–253, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. J. B. K. Sailaja, V. Balasubramaniyan, and N. Nalini, “Effect of exogenous leptin administration on high fat diet induced oxidative stress,” Pharmazie, vol. 59, no. 6, pp. 475–479, 2004. View at Google Scholar · View at Scopus
  36. S. Gülen and S. Dinçer, “Effects of leptin on oxidative stress in healthy and Streptozotocin-induced diabetic rats,” Molecular and Cellular Biochemistry, vol. 302, no. 1-2, pp. 59–65, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. R. D. Hoeldtke, K. D. Bryner, D. R. McNeill, S. S. Warehime, K. Van Dyke, and G. Hobbs, “Oxidative stress and insulin requirements in patients with recent-onset type I diabetes,” Journal of Clinical Endocrinology and Metabolism, vol. 88, no. 4, pp. 1624–1628, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. E. D. Harris, “Regulation of antioxidant enzymes,” FASEB Journal, vol. 6, no. 9, pp. 2675–2683, 1992. View at Google Scholar · View at Scopus
  39. A. M. Watson, S. M. Poloyac, G. Howard, and R. A. Blouin, “Effect of leptin on cytochrome P-450, conjugation, and antioxidant enzymes in the ob/ob mouse,” Drug Metabolism and Disposition, vol. 27, no. 6, pp. 695–700, 1999. View at Google Scholar · View at Scopus
  40. M. Ozata, G. Uckaya, A. Aydin, A. Isimer, and I. C. Ozdemir, “Defective antioxidant defense system in patients with a human leptin gene mutation,” Hormone and Metabolic Research, vol. 32, no. 7, pp. 269–272, 2000. View at Google Scholar · View at Scopus
  41. J. C. Pickup and M. B. Mattock, “Activation of the innate immune system as a predictor of cardiovascular mortality in Type 2 diabetes mellitus,” Diabetic Medicine, vol. 20, no. 9, pp. 723–726, 2003. View at Publisher · View at Google Scholar · View at Scopus
  42. L. Kjeldsen, J. B. Cowland, and N. Borregaard, “Human neutrophil gelatinase-associated lipocalin and homologous proteins in rat and mouse,” Biochimica et Biophysica Acta, vol. 1482, no. 1-2, pp. 272–283, 2000. View at Publisher · View at Google Scholar · View at Scopus
  43. C. Gabay and I. Kushner, “Acute-phase proteins and other systemic responses to inflammation,” The New England Journal of Medicine, vol. 340, no. 6, pp. 448–454, 1999. View at Publisher · View at Google Scholar · View at Scopus
  44. V. Catalán, J. Gómez-Ambrosi, A. Rodríguez et al., “Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans,” Journal of Molecular Medicine, vol. 87, no. 8, pp. 803–813, 2009. View at Publisher · View at Google Scholar · View at Scopus
  45. J. S. Moylan and M. B. Reid, “Oxidative stress, chronic disease, and muscle wasting,” Muscle and Nerve, vol. 35, no. 4, pp. 411–429, 2007. View at Publisher · View at Google Scholar · View at Scopus
  46. Y.-P. Li, Y. Chen, A. S. Li, and M. B. Reid, “Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes,” American Journal of Physiology, vol. 285, no. 4, pp. C806–C812, 2003. View at Google Scholar · View at Scopus
  47. P. Matthys and A. Billiau, “Cytokines and cachexia,” Nutrition, vol. 13, no. 9, pp. 763–770, 1997. View at Publisher · View at Google Scholar · View at Scopus
  48. C. Ebisui, T. Tsujinaka, T. Morimoto et al., “Interleukin-6 induces proteolysis by activating intracellular proteases (cathepsins B and L, proteasome) in C2C12 myotubes,” Clinical Science, vol. 89, no. 4, pp. 431–439, 1995. View at Google Scholar · View at Scopus
  49. C. Deval, S. Mordier, C. Obled et al., “Identification of cathepsin L as a differentially expressed message associated with skeletal muscle wasting,” Biochemical Journal, vol. 360, no. 1, pp. 143–150, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. Y.-P. Li, Y. Chen, J. John et al., “TNF-α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle,” FASEB Journal, vol. 19, no. 3, pp. 362–370, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. J. St-Amand, K. Okamura, K. Matsumoto, S. Shimizu, and Y. Sogawa, “Characterization of control and immobilized skeletal muscle: an overview from genetic engineering,” FASEB Journal, vol. 15, no. 3, pp. 684–692, 2001. View at Publisher · View at Google Scholar · View at Scopus
  52. M. Wittwer, M. Flück, H. Hoppeler, S. Müller, D. Desplanches, and R. Billeter, “Prolonged unloading of rat soleus muscle causes distinct adaptations of the gene profile,” FASEB Journal, vol. 16, no. 8, pp. 884–886, 2002. View at Google Scholar · View at Scopus
  53. R. Nath, D. Kumar, T. Li, and P. K. Singal, “Metallothioneins, oxidative stress and the cardiovascular system,” Toxicology, vol. 155, no. 1–3, pp. 17–26, 2000. View at Publisher · View at Google Scholar · View at Scopus
  54. E. J. Stevenson, P. G. Giresi, A. Koncarevic, and S. C. Kandarian, “Global analysis of gene expression patterns during disuse atrophy in rat skeletal muscle,” Journal of Physiology, vol. 551, no. 1, pp. 33–48, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. S. H. Lecker, R. T. Jagoe, A. Gilbert et al., “Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression,” FASEB Journal, vol. 18, no. 1, pp. 39–51, 2004. View at Publisher · View at Google Scholar · View at Scopus
  56. M. L. Urso, P. M. Clarkson, and T. B. Price, “Immobilization effects in young and older adults,” European Journal of Applied Physiology, vol. 96, no. 5, pp. 564–571, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. R. I. Morimoto, “Cells in stress: transcriptional activation of heat shock genes,” Science, vol. 259, no. 5100, pp. 1409–1410, 1993. View at Google Scholar · View at Scopus
  58. C.-K. Lee, R. G. Klopp, R. Weindruch, and T. A. Prolla, “Gene expression profile of aging and its retardation by caloric restriction,” Science, vol. 285, no. 5432, pp. 1390–1393, 1999. View at Publisher · View at Google Scholar · View at Scopus
  59. J. M. Lawler, W. Song, and H.-B. Kwak, “Differential response of heat shock proteins to hindlimb unloading and reloading in the soleus,” Muscle and Nerve, vol. 33, no. 2, pp. 200–207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  60. J. T. Selsby, S. Rother, S. Tsuda, O. Pracash, J. Quindry, and S. L. Dodd, “Intermittent hyperthermia enhances skeletal muscle regrowth and attenuates oxidative damage following reloading,” Journal of Applied Physiology, vol. 102, no. 4, pp. 1702–1707, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Liu, L. Gampert, K. Nething, and J. M. Steinacker, “Response and function of skeletal muscle heat shock protein 70,” Frontiers in Bioscience, vol. 11, no. 3, pp. 2802–2827, 2006. View at Publisher · View at Google Scholar · View at Scopus
  62. H. Naito, S. K. Powers, H. A. Demirel, T. Sugiura, S. L. Dodd, and J. Aoki, “Heat stress attenuates skeletal muscle atrophy in hindlimb-unweighted rats,” Journal of Applied Physiology, vol. 88, no. 1, pp. 359–363, 2000. View at Google Scholar · View at Scopus
  63. J. T. Selsby and S. L. Dodd, “Heat treatment reduces oxidative stress and protects muscle mass during immobilization,” American Journal of Physiology, vol. 289, no. 1, pp. R134–R139, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. S. M. Senf, S. L. Dodd, J. M. McClung, and A. R. Judge, “Hsp70 overexpression inhibits NF-κB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy,” FASEB Journal, vol. 22, no. 11, pp. 3836–3845, 2008. View at Publisher · View at Google Scholar · View at Scopus
  65. C. Garrido, S. Gurbuxani, L. Ravagnan, and G. Kroemer, “Heat shock proteins: endogenous modulators of apoptotic cell death,” Biochemical and Biophysical Research Communications, vol. 286, no. 3, pp. 433–442, 2001. View at Publisher · View at Google Scholar · View at Scopus
  66. M. C. Kamradt, F. Chen, S. Sam, and V. L. Cryns, “The small heat shock protein αB-crystallin negatively regulates apoptosis during myogenic differentiation by inhibiting caspase-3 activation,” The Journal of Biological Chemistry, vol. 277, no. 41, pp. 38731–38736, 2002. View at Publisher · View at Google Scholar · View at Scopus
  67. T. Nakamura and K. Sakamoto, “Forkhead transcription factor FOXO subfamily is essential for reactive oxygen species-induced apoptosis,” Molecular and Cellular Endocrinology, vol. 281, no. 1-2, pp. 47–55, 2008. View at Publisher · View at Google Scholar · View at Scopus
  68. M. C. C. Gomes-Marcondes and M. J. Tisdale, “Induction of protein catabolism and the ubiquitin-proteasome pathway by mild oxidative stress,” Cancer Letters, vol. 180, no. 1, pp. 69–74, 2002. View at Publisher · View at Google Scholar · View at Scopus
  69. M. F. McCarty, “Induction of heat shock proteins may combat insulin resistance,” Medical Hypotheses, vol. 66, no. 3, pp. 527–534, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. K. B. Aly, J. L. Pipkin, W. G. Hinson et al., “Chronic caloric restriction induces stress proteins in the hypothalamus of rats,” Mechanisms of Ageing and Development, vol. 76, no. 1, pp. 11–23, 1994. View at Publisher · View at Google Scholar · View at Scopus
  71. A. R. Heydari, S. You, R. Takahashi, A. Gutsmann, K. D. Sarge, and A. Richardson, “Effect of caloric restriction on the expression of heat shock protein 70 and the activation of heat shock transcription factor,” Developmental Genetics, vol. 18, no. 2, pp. 114–124, 1996. View at Google Scholar · View at Scopus
  72. I. Kurucz, A. Morva, A. Vaag et al., “Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance,” Diabetes, vol. 51, no. 4, pp. 1102–1109, 2002. View at Google Scholar · View at Scopus
  73. C. R. Bruce, A. L. Carey, J. A. Hawley, and M. A. Febbraio, “Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism,” Diabetes, vol. 52, no. 9, pp. 2338–2345, 2003. View at Publisher · View at Google Scholar · View at Scopus
  74. D. Figueiredo, A. Gertler, G. Cabello, E. Decuypere, J. Buyse, and S. Dridi, “Leptin downregulates heat shock protein-70 (HSP-70) gene expression in chicken liver and hypothalamus,” Cell and Tissue Research, vol. 329, no. 1, pp. 91–101, 2007. View at Publisher · View at Google Scholar · View at Scopus
  75. J. Bonior, J. Jaworek, S. J. Konturek, and W. W. Pawlik, “Leptin is the modulator of HSP60 gene expression in AR42J cells,” Journal of Physiology and Pharmacology, vol. 57, no. 7, pp. 135–143, 2006. View at Google Scholar · View at Scopus